Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020
Limited clinical value of exhaled volatile organic compound measurements in childhood asthma Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018 Year: 2018
Can exhaled volatile organic compounds predict asthma exacerbations in children? Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015
Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial Source: ERJ Open Res, 7 (4) 00253-2021; 10.1183/23120541.00253-2021 Year: 2021
Exhaled carbon monoxide in asthma: a prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003
Exhaled breath profiling in diagnosing wheezy preschool children Source: Eur Respir J 2013; 41: 183-188 Year: 2013
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Exhaled volatile organic compounds differentiate between children with atopic asthma and healthy controls Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020 Year: 2021
Exhaled NO as a part of a clinical evaluation of asthma in young children Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006
Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test? Source: Eur Respir J, 55 (2) 1902112; 10.1183/13993003.02112-2019 Year: 2020
Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018
Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010
Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate Source: Eur Respir J 2002; 20: Suppl. 38, 275s Year: 2002
Exhaled air volatile organic compounds and eosinophilic airway inflammation in asthma Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012
Exhaled NO in the long-term management of asthma a review of the evidence Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006
Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018